Method Development & Validation CDMOs

Aparna Pharmaceuticals Pvt Ltd

India

Aparna Pharmaceuticals is an Indian company specializing in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. They offer contract manufacturing services for global clients with a focus on quality-driven API production using dedicated facilities.

Applied StemCell

United States

Applied StemCell is a CRO/CDMO based in the United States specializing in cell and gene therapy. The company provides genome engineering services using CRISPR, Mad7, and their proprietary TARGATT large cargo knock-in platform. They operate a cGMP manufacturing facility that supports iPSC-based and antibody-based advanced therapeutics, from cell line development through process development and GMP manufacturing.

Archimica S.p.A.

Italy

Archimica S.p.A. is an Italian CDMO specializing in active pharmaceutical ingredients (APIs) and advanced intermediates. Based in Lodi, Italy, they are known for experience with the most challenging reagents, reactions, and substance classes in chemical synthesis. The company was acquired by PI Health Sciences in 2023. They hold FDA registration with operations in analysis and API manufacture, and have a strong track record of CEP/DMF filings for their products.

Arevipharma GmbH

Germany

Arevipharma GmbH is a German CDMO based in Radebeul with nearly 150 years of corporate history in synthetic API manufacturing. They produce active pharmaceutical ingredients from gram scale up to several hundred tons per year under cGMP standards across five production scales. They serve small, medium, and large pharmaceutical customers worldwide with API manufacturing, registration, and marketing services. They are FDA-registered for API manufacture.

Arran Chemical Company (Almac Group)

Ireland

Arran Chemical Company, now part of the Almac Group, is an Irish chemical manufacturer with over 40 years of experience specializing in custom synthesis of pharmaceutical intermediates, APIs, and registered starting materials (RSMs). Based in Athlone, Ireland, they offer specialized reaction technology including organometallic synthesis, catalytic transfer hydrogenation, and biocatalysis/chemocatalysis capabilities from kilo lab/pilot plant (10L to 1400L) through multi-tonne commercial scale.

Arxada (CDMO)

Australia

Arxada (formerly part of Lonza Specialty Ingredients) is a CDMO with over 40 years of experience in custom development and manufacturing of advanced intermediates and active ingredients. They operate from sites in Visp (Switzerland) and Kourim (Czech Republic), offering both chemical synthesis and biotechnology/fermentation routes from gram to multi-metric-ton commercial scale. Their backward-integrated site with on-site waste and energy management provides a comprehensive CDMO offering spanning process development, analytical development, formulation, and regulatory support.

AXOlabs

Germany

AXOlabs is an integrated CRO/CDMO specializing in nucleic acid therapeutics (oligonucleotides). Their platform spans from discovery (lead identification and chemistry optimization using bioinformatics-driven design and high-throughput screening) through preclinical safety/PK studies and GLP-compliant bioanalysis to GMP-compliant manufacturing of ASOs, siRNAs, sgRNAs, aptamers, and bioconjugates for clinical phases I-III and initial commercial supply. AXOlabs operates dual-site, globally integrated facilities in Petaluma, California (USA) and Berlin/Kulmbach (Germany), equipped with Cytiva OligoPilot, OligoProcess, and Asahi Kasei THESYS platforms. The company partners with Codexis on enzymatic RNA manufacturing and with Asahi Kasei on oligonucleotide production technologies.

BBT Biotech GmbH

Germany

BBT Biotech GmbH is a German CDMO specializing in pharmaceutical active ingredients of biological origin. Based in Baesweiler near Aachen, they focus on fermentation (upstream processing) and protein purification (downstream processing) for the development, manufacture, and international distribution of biopharmaceuticals. They have had 1 FDA inspection with an OAI outcome.

BianoScience GmbH

Germany

BianoScience GmbH (rebranded to XNApharma GmbH in 2024) is a specialist CDMO focused on oligonucleotide synthesis and manufacturing, from R&D scale through GMP production. Based in Gera, Germany, the company provides custom oligonucleotide synthesis, modifications, analytics, and large-scale/GMP oligonucleotide manufacturing for clinical and commercial use.

Bionex Pharmaceuticals LLC is a US-based pharmaceutical development CRMO (Contract Research and Manufacturing Organization) specializing in novel topical, transdermal/transmucosal, and implant drug delivery systems. They offer pre-formulation through clinical supply manufacturing, with many R&D projects funded by NIH and NSF grants. Located at the New Jersey Bioscience Center. They have had 3 FDA recalls (1 Class I, 2 Class II).

BioReliance (Merck KGaA, MilliporeSigma)

Scotland

BioReliance is the contract testing services division of Merck KGaA (MilliporeSigma), providing GMP-compliant biosafety testing, product characterization, and quality control testing for biologics, vaccines, and cell/gene therapies. With 25 FDA-registered FEI numbers and 102 FDA inspections across global sites, they are one of the largest contract testing organizations. They provide end-to-end testing solutions but do NOT manufacture drug substances or drug products -- they are a testing CRO.

Biotimize – Biotechnology as a Service (BTaaS)

Brazil

Biotimize is the first CDMO for biopharmaceuticals in Brazil, dedicated to maximizing the development and production of biopharmaceuticals. The company provides personalized biotechnology and bioprocess engineering-based services (currently non-GMP) to biopharmaceutical companies and is building a new GMP production platform on over 20,000 square meters. Biotimize offers bioproduct development and biotechnology-as-a-service (BTaaS).

Blue Jet Healthcare

India

Blue Jet Healthcare is a Mumbai-headquartered, global, science-led pharmaceutical company operating as a strategic partner for collaboration, development, and manufacturing of advanced pharmaceutical intermediates and APIs. The company has 4 manufacturing facilities in Maharashtra and is investing Rs 2,300 crore in a 102-acre mega greenfield manufacturing facility in Andhra Pradesh to expand its CDMO capabilities. Blue Jet specializes in contrast media intermediates, artificial sweeteners (saccharin), and custom synthesis and development.

Bushu Pharma is Japan's premier CDMO with over 25 years of experience, specializing in contract manufacturing of solid dosage formulations, sterile injectables, lyophilized products, and prefilled syringes for both clinical trial supplies and commercial products. The company operates five factories in Japan with GMP certifications from 56 countries including FDA, EMA, and PMDA, serving over 90 pharmaceutical companies globally with nearly 50% of sales from foreign-affiliated clients.

Capot Chemical Co., Ltd.

China

Capot Chemical Co., Ltd. is a custom synthesis CDMO based in Hangzhou, China, established in 1996 with over 20 years of experience. The company provides custom synthesis, scale-up, and contract manufacturing services for pharmaceutical intermediates and APIs, serving the pharmaceutical industry from R&D through commercial production.

CatSci Ltd

United Kingdom

CatSci Ltd is a UK-based contract development organization specializing in small molecule therapies and complex synthetic medicines development. The company provides integrated R&D services from early discovery through to post-approval support, partnering with global biotech and pharma teams including 7 of the top 10 pharma companies. CatSci combines chemistry, biology, process, and analytical expertise with digital workflows to accelerate drug development.

Celerion

Austria

Celerion is a clinical research organization (CRO) specializing in early-phase (Phase I) clinical trials and translational medicine. The company provides clinical research solutions, innovative technologies, and therapeutic and specialty expertise to help get drugs to market faster. Celerion offers specialized procedures including echocardiograms, CSF collection, cognitive testing, imaging, and molecular/cellular capabilities including flow cytometry and ELISpot testing.

Cenra Pharma (formerly CCPC, China Chemical & Pharmaceutical Co.) is a Taiwanese pharmaceutical company established in 1952 that develops and manufactures APIs and generic drugs, also providing CMO/CDMO services. The company has FDA and PMDA facility approvals, PIC/S GMP compliance, and offers services from API selection through formulation development and commercial manufacturing. Cenra specializes in high-potency drugs including immunosuppressants and oncology drugs, with dedicated production lines for penicillins, cephalosporins, carbapenems, and immunosuppressants.

Centroflora Group

Brazil

Centroflora Group is a Brazilian company specializing in the manufacturing of plant-based active pharmaceutical ingredients (APIs), food ingredients, and cosmetic ingredients from natural extracts. The company offers CDMO outsourcing services including API manufacturing, extract development, analytical methodology development and validation, and regulatory consulting. Centroflora has FDA registration for API manufacture and analysis, with 5 FDA inspections through November 2024.

Chiracon GmbH

Germany

Chiracon GmbH, founded in 1998, is a German API manufacturer and CDMO based in Brandenburg with over 25 years of experience. The company provides contract research, intermediates, scale-up, GMP-quality API manufacturing, stability studies, and clinical trial supplies for the pharmaceutical industry.

Cleanchem Laboratories LLP

India

Cleanchem Laboratories LLP is an Indian company specializing in impurity reference standards, nitrosamine standards, API intermediates, and custom peptide synthesis. The company offers CDMO services for peptide manufacturing, along with purification services including flash chromatography, unknown impurity isolation and identification, and analytical services for pharmaceutical substances.

Clearsynth

Canada

Clearsynth is a technology-based research-driven enterprise headquartered in Mumbai with operations in Canada, US, Europe, and India. The company offers CDMO services for small molecule manufacturing from milligram to multi-tonne scale under GMP conditions, along with reference standards, stable isotope labeled compounds, contract R&D synthesis, process development, and analytical services including BIO NMR at its 50,000+ sq ft R&D facility in Hyderabad.

Creative Biogene

United States

Creative Biogene is a US-based biotech CDMO offering microbial production services for drug substances, GMP-grade mRNA production, and cGMP cell line development. The company provides end-to-end services from oligonucleotide R&D to drug product manufacturing, with capabilities spanning bacterial and yeast-based production systems.

Creative Peptides

United States

Creative Peptides is a New York-based CDMO specializing in custom peptide synthesis, process development, and cGMP peptide manufacturing from R&D-grade to commercial scale. The company offers end-to-end peptide services including peptide conjugation, PEGylation, lipidation, structural modifications, and peptide labeling for pharmaceutical and biotech clients.

CTX Life Sciences Pvt. Ltd.

India

CTX Life Sciences Pvt. Ltd. is a vertically integrated API and intermediate manufacturer based near Surat, Gujarat, India. The company operates a world-class manufacturing facility with a total area of 147,227 sqm, capable of handling complex and hazardous reactions, with DSIR-approved R&D and a collective reactor capacity of around 900 KL. The facility has been inspected by US FDA (6 times), EDQM, BfArM (Germany), TGA (Australia), PMDA (Japan), Health Canada, ANVISA (Brazil), and COFEPRIS (Mexico).

DIATHEVA

Italy

Diatheva is an Italian biotech CDMO founded in 2002 as a spin-off from the University of Urbino, specializing in small-scale GMP manufacturing of biotechnological products for third parties. They offer contract development and production of monoclonal antibodies, polyclonal antibodies, antibody fragments, recombinant proteins, enzymes, and antigens, with AIFA-authorized GMP facilities since 2006 for biomolecules and since 2023 for medicinal products.

DINAMIQS

Switzerland

DINAMIQS is a Swiss CDMO for AAV and lentiviral vector manufacturing, part of the Siegfried group since May 2023. In September 2025 they opened a 2,500 sq m cGMP facility in Zurich's Bio-Technopark for viral vector gene therapy manufacturing, supporting R&D through commercial scale. They licensed ExcellGene's HEKExpress and HEK2Express cell line technologies for GMP viral vector production.

Dipharma Francis S.r.l.

Italy

Dipharma Francis S.r.l. is an Italian CDMO and manufacturer of Active Pharmaceutical Ingredients and advanced intermediates, offering exclusive synthesis services for custom API development and manufacturing alongside a catalogue of generic APIs. They have completed a second phase of cGMP expansion and operate multiple global locations supporting pharmaceutical customers from development through commercial supply.

Dishman Carbogen Amcis Ltd

China

Dishman Carbogen Amcis Ltd is a global CDMO and pharmaceutical outsourcing partner with operations across India, Switzerland, UK, France, Netherlands, and China. With 30 years of experience, they offer custom API development and manufacturing up to 100 metric ton scale, drug product capabilities including highly potent compounds and ADCs, plus finished dosage forms including soft gel capsules and encapsulation. They have received successful USFDA, PMDA, and EDQM inspections.

Diverchim CDMO

France

Diverchim is a French boutique CDMO founded in 2000, specializing in developing and manufacturing small-quantity Active Pharmaceutical Ingredients including drug candidates, orphan drug APIs, and radiopharmaceutical precursors. They offer services from preclinical stage through commercial supply, with GMP certification since 2015, FDA site registration since 2021, and capabilities including lyophilization and solid aliquoting of radiopharmaceutical precursors.

Divis Laboratories Limited

India

Divis Laboratories is one of the world's top 3 API manufacturers and a trusted CDMO partner for over 25 years, serving 12 of the top 20 Big Pharma companies. Operating three world-class manufacturing facilities near Hyderabad, Visakhapatnam, and Kakinada in India with over 16,500 m3 combined reaction capacity, they manufacture generic APIs (30 commercial products), custom synthesis for Big Pharma (small molecules, high potent, peptides), and nutraceutical ingredients including carotenoids and vitamins.

Domixtar Pharmaceuticals SpA

Italy

Domixtar Pharmaceuticals (DMX Pharma) is Italy's largest CDMO, formed from the merger of Doppel Farmaceutici and Mipharm, and part of the group that includes Alfa Omega for nutraceuticals. With 1,000 professionals serving 105 partners across 30 countries, they offer full-service outsourcing from formulation development through post-marketing, including production, packaging, R&D, logistics, and quality control for pharmaceutical products.

DPT Laboratories, LTD.

United States

DPT Laboratories, Ltd., a Mylan company with over 80 years of experience, is a leading CDMO specializing in semi-solid and liquid dosage forms including creams, gels, ointments, lotions, solutions, suspensions, emulsions, and aerosol formulations. The company provides integrated services from pre-formulation through commercial-scale cGMP manufacturing and packaging.

ElevateBio (BaseCamp)

United States

ElevateBio is a US-based genetic medicines company whose BaseCamp division operates as a cGMP manufacturing CDMO for cell therapy, gene therapy, and mRNA products. BaseCamp provides development and manufacturing services from concept through commercialization, leveraging state-of-the-art facilities and proprietary technologies. The company has achieved six consecutive years of revenue growth and holds ICMC certification for its manufacturing operations.

Emmennar Pharma Private Limited

India

Emmennar Pharma Private Limited (operating as Emnar Pharma) is an Indian API manufacturer based in Hyderabad, part of the Virchow group of companies. The company specializes in the manufacture and supply of generic Active Pharmaceutical Ingredients with USFDA, EDQM (EU GMP), and KFDA-approved manufacturing facilities. Emmennar has filed 26 USMDFs, delivered 40 APIs, and holds 250+ product test licenses with 20+ products in the pipeline and 750+ employees.

Eromol UK Ltd (Eramol)

United Kingdom

Eramol (formerly Eromol UK Ltd) is a UK-based CDMO specializing in bespoke clinical trial manufacturing services, founded by two Qualified Persons. The company provides end-to-end services including formulation development, primary manufacturing, clinical packaging, QP release, and global distribution from MHRA and HPRA-approved facilities, with a new sterile injectable site opening in early 2026.

Esteve CDMO (Esteve Química)

Spain

Esteve CDMO (Esteve Quimica) is a global pure-play third-party CDMO specializing in high-quality small-molecule active pharmaceutical ingredients. The company operates manufacturing sites in Spain and recently acquired Regis Technologies to expand U.S. capabilities, with FDA-registered facilities across multiple locations.

EUROAPI

France

EuroAPI is the global leader in small molecule APIs with a unique European industrial footprint of 6 manufacturing sites. Spun out from Sanofi with 15 years of oligonucleotide and 45 years of peptide experience, the company provides full CMC services from drug substance development through registration and commercial supply, including complex molecule segments like Tides (peptides and oligonucleotides).

Eurofins Biopharma Services (CDMO)

Australia

Eurofins Biopharma Services CDMO is a division of Eurofins Scientific offering integrated API and drug product outsourcing services across small molecules and biologics. The company provides services from early-stage development through commercial manufacturing including highly potent drug development, sterile manufacturing/fill-finish, lyophilization, and biologics development through its Alphora brand.

Euticals (now part of Curia)

France

Euticals, now part of Curia Global, is a global CDMO with over 30 years of experience in drug discovery, development, and manufacturing across small molecules, generic APIs, sterile drug products, and biologics. Curia (which acquired Euticals through AMRI) operates an extensive global network with hundreds of FDA-registered facilities and provides end-to-end services from API manufacturing through sterile fill/finish.

Evonik Industries AG

Canada

Evonik Industries AG is a global specialty chemicals company that operates as a leading CDMO for complex parenteral drug products, focusing on polymeric and lipid-based delivery systems including liposomes, nanoparticles, microparticles, implants, and LNP formulations. The company's Health Care division provides end-to-end CDMO services for small molecules, peptides, nucleic acids (mRNA, siRNA), and HPAPIs, with FDA-inspected facilities in the US and Canada and 34 FDA inspections with zero OAI outcomes.

FAMAR

Greece

FAMAR is a leading European pharmaceutical CDMO headquartered in Greece with a network of 7 production sites and 2 R&D centers across Europe, employing approximately 1,800 people. The company provides development, manufacturing, quality, regulatory, and logistics services for a wide range of pharmaceutical and consumer care products across 80+ international markets, with capabilities spanning from oral solid dose to sterile injectables and HPAPI products.

Fermion, a wholly owned subsidiary of Orion Corporation (Finland), is a CDMO specializing in developing, manufacturing, and marketing small molecule Active Pharmaceutical Ingredients (APIs), including HPAPIs, cytotoxics, steroids, generics, and controlled substances. Together with its parent Orion, it offers integrated contract development and manufacturing services for both drug substances and drug products, covering the full lifecycle from preclinical to commercial scale. FDA-approved since 1979 and EMA-approved since 1971.

Formulated Solutions

United States

Formulated Solutions is a U.S.-based CDMO providing formulation development, analytical development, manufacturing, regulatory affairs, and packaging services for pharmaceutical and consumer health products. The company offers flexible manufacturing from small-scale clinical batches to large-scale commercial production across multiple dosage forms.

Formulytica

Australia

Formulytica is an Australian specialty contract research, development and manufacturing organisation (CRDMO) with expertise in formulation, analytical method development, and drug product development. The company specializes in developing innovative drug formulations and analytical methods essential for clinical trial entry.

Fortrea

United States

Fortrea is a leading global contract research organization (CRO) spun off from Labcorp in 2023, providing Phase I through IV clinical trial management, clinical pharmacology, and market access solutions for biopharma and MedTech companies. While Fortrea has some onsite Phase I manufacturing capability for small molecule clinical supplies, its core business is clinical trial services, not contract drug manufacturing.

Fujirebio

Belgium

Fujirebio is a global in vitro diagnostics (IVD) company with over 50 years of expertise in biomarker innovation, offering CDMO services for diagnostic products. The company provides contract development and manufacturing for diagnostic partners, including reagent development, manufacturing, and clinical and regulatory services. Fujirebio is particularly known for its FDA-cleared Alzheimer's disease blood-based biomarkers on its Lumipulse platform.

Gaelic Laboratories Limited

Ireland

Gaelic Laboratories Limited is an Irish contract manufacturer specializing in Beta-Lactam (penicillin) products in tablet, capsule, and powder for suspension form. Established in 2022 on a site with 40 years of FDA-approved Beta-Lactam manufacturing history, the company serves EU, UK, and MENA markets. The facility spans 8,000 sqm across two GMP manufacturing plants on an 11-acre site, with HPRA licensing.